Dr Vinod Mohan, MD | |
417 State St Ste 412, Bangor, ME 04401-6639 | |
(207) 973-4377 | |
(207) 973-5810 |
Full Name | Dr Vinod Mohan |
---|---|
Gender | Male |
Speciality | Infectious Disease |
Experience | 16 Years |
Location | 417 State St Ste 412, Bangor, Maine |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326351594 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RI0200X | Internal Medicine - Infectious Disease | MD20479 (Maine) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Heywood Hospital - | Gardner, MA | Hospital |
Athol Memorial Hospital | Athol, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Heywood Medical Group Inc. | 6901882836 | 82 |
News Archive
Amarantus BioSciences, Inc., a biotechnology company developing new treatments for brain-related disorders including traumatic brain injury (TBI) based on its proprietary anti-apoptotic therapeutic protein known as MANF and Banyan Biomarkers, the leader in developing in vitro diagnostic products to detect TBI, today announced the successful completion of a collaboration agreement initiated in November 2011 to evaluate MANF's potential as a disease-modifying agent for the treatment of TBI.
Nebraska officials raised concerns Monday about the state's ability to meet upcoming federal health care reform deadlines. At a briefing for state lawmakers, the officials said they face challenges with the amount of work to be done and the lack of answers on key matters.
Researchers at Johns Hopkins have discovered that cancers arising from epigenetic changes - in this case the inappropriate activation of a normally silent gene - develop by becoming addicted to certain growth factors.
The World Health Organization Framework Convention on Tobacco Control (WHO FCTC) entered into force today. This represents an historical moment in public health, as the Treaty gives countries more tools to control tobacco use and save lives.
Dental implants are now a common way to replace a tooth. But a dentist must first determine that an implant restoration can be successful for a particular patient. As an indicator, dentists use the crown-to-root ratio—how much of the tooth extends above the jawbone and how much is in the bone. However, the ideal crown-to-implant ratio for the replacement tooth has yet to be determined.
› Verified 5 days ago
Entity Name | Henry Heywood Memorial Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1205823879 PECOS PAC ID: 1658262605 Enrollment ID: O20040322000360 |
News Archive
Amarantus BioSciences, Inc., a biotechnology company developing new treatments for brain-related disorders including traumatic brain injury (TBI) based on its proprietary anti-apoptotic therapeutic protein known as MANF and Banyan Biomarkers, the leader in developing in vitro diagnostic products to detect TBI, today announced the successful completion of a collaboration agreement initiated in November 2011 to evaluate MANF's potential as a disease-modifying agent for the treatment of TBI.
Nebraska officials raised concerns Monday about the state's ability to meet upcoming federal health care reform deadlines. At a briefing for state lawmakers, the officials said they face challenges with the amount of work to be done and the lack of answers on key matters.
Researchers at Johns Hopkins have discovered that cancers arising from epigenetic changes - in this case the inappropriate activation of a normally silent gene - develop by becoming addicted to certain growth factors.
The World Health Organization Framework Convention on Tobacco Control (WHO FCTC) entered into force today. This represents an historical moment in public health, as the Treaty gives countries more tools to control tobacco use and save lives.
Dental implants are now a common way to replace a tooth. But a dentist must first determine that an implant restoration can be successful for a particular patient. As an indicator, dentists use the crown-to-root ratio—how much of the tooth extends above the jawbone and how much is in the bone. However, the ideal crown-to-implant ratio for the replacement tooth has yet to be determined.
› Verified 5 days ago
Entity Name | Heywood Medical Group Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1699762286 PECOS PAC ID: 6901882836 Enrollment ID: O20040629001351 |
News Archive
Amarantus BioSciences, Inc., a biotechnology company developing new treatments for brain-related disorders including traumatic brain injury (TBI) based on its proprietary anti-apoptotic therapeutic protein known as MANF and Banyan Biomarkers, the leader in developing in vitro diagnostic products to detect TBI, today announced the successful completion of a collaboration agreement initiated in November 2011 to evaluate MANF's potential as a disease-modifying agent for the treatment of TBI.
Nebraska officials raised concerns Monday about the state's ability to meet upcoming federal health care reform deadlines. At a briefing for state lawmakers, the officials said they face challenges with the amount of work to be done and the lack of answers on key matters.
Researchers at Johns Hopkins have discovered that cancers arising from epigenetic changes - in this case the inappropriate activation of a normally silent gene - develop by becoming addicted to certain growth factors.
The World Health Organization Framework Convention on Tobacco Control (WHO FCTC) entered into force today. This represents an historical moment in public health, as the Treaty gives countries more tools to control tobacco use and save lives.
Dental implants are now a common way to replace a tooth. But a dentist must first determine that an implant restoration can be successful for a particular patient. As an indicator, dentists use the crown-to-root ratio—how much of the tooth extends above the jawbone and how much is in the bone. However, the ideal crown-to-implant ratio for the replacement tooth has yet to be determined.
› Verified 5 days ago
Entity Name | Athol Memorial Hospital Incorporated |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1336120047 PECOS PAC ID: 7911959846 Enrollment ID: O20050218000228 |
News Archive
Amarantus BioSciences, Inc., a biotechnology company developing new treatments for brain-related disorders including traumatic brain injury (TBI) based on its proprietary anti-apoptotic therapeutic protein known as MANF and Banyan Biomarkers, the leader in developing in vitro diagnostic products to detect TBI, today announced the successful completion of a collaboration agreement initiated in November 2011 to evaluate MANF's potential as a disease-modifying agent for the treatment of TBI.
Nebraska officials raised concerns Monday about the state's ability to meet upcoming federal health care reform deadlines. At a briefing for state lawmakers, the officials said they face challenges with the amount of work to be done and the lack of answers on key matters.
Researchers at Johns Hopkins have discovered that cancers arising from epigenetic changes - in this case the inappropriate activation of a normally silent gene - develop by becoming addicted to certain growth factors.
The World Health Organization Framework Convention on Tobacco Control (WHO FCTC) entered into force today. This represents an historical moment in public health, as the Treaty gives countries more tools to control tobacco use and save lives.
Dental implants are now a common way to replace a tooth. But a dentist must first determine that an implant restoration can be successful for a particular patient. As an indicator, dentists use the crown-to-root ratio—how much of the tooth extends above the jawbone and how much is in the bone. However, the ideal crown-to-implant ratio for the replacement tooth has yet to be determined.
› Verified 5 days ago
Entity Name | Partners In Internal Medicine Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1588680946 PECOS PAC ID: 8527081009 Enrollment ID: O20060111000149 |
News Archive
Amarantus BioSciences, Inc., a biotechnology company developing new treatments for brain-related disorders including traumatic brain injury (TBI) based on its proprietary anti-apoptotic therapeutic protein known as MANF and Banyan Biomarkers, the leader in developing in vitro diagnostic products to detect TBI, today announced the successful completion of a collaboration agreement initiated in November 2011 to evaluate MANF's potential as a disease-modifying agent for the treatment of TBI.
Nebraska officials raised concerns Monday about the state's ability to meet upcoming federal health care reform deadlines. At a briefing for state lawmakers, the officials said they face challenges with the amount of work to be done and the lack of answers on key matters.
Researchers at Johns Hopkins have discovered that cancers arising from epigenetic changes - in this case the inappropriate activation of a normally silent gene - develop by becoming addicted to certain growth factors.
The World Health Organization Framework Convention on Tobacco Control (WHO FCTC) entered into force today. This represents an historical moment in public health, as the Treaty gives countries more tools to control tobacco use and save lives.
Dental implants are now a common way to replace a tooth. But a dentist must first determine that an implant restoration can be successful for a particular patient. As an indicator, dentists use the crown-to-root ratio—how much of the tooth extends above the jawbone and how much is in the bone. However, the ideal crown-to-implant ratio for the replacement tooth has yet to be determined.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Vinod Mohan, MD Po Box 3491, Worcester, MA 01613-3491 Ph: (508) 363-7300 | Dr Vinod Mohan, MD 417 State St Ste 412, Bangor, ME 04401-6639 Ph: (207) 973-4377 |
News Archive
Amarantus BioSciences, Inc., a biotechnology company developing new treatments for brain-related disorders including traumatic brain injury (TBI) based on its proprietary anti-apoptotic therapeutic protein known as MANF and Banyan Biomarkers, the leader in developing in vitro diagnostic products to detect TBI, today announced the successful completion of a collaboration agreement initiated in November 2011 to evaluate MANF's potential as a disease-modifying agent for the treatment of TBI.
Nebraska officials raised concerns Monday about the state's ability to meet upcoming federal health care reform deadlines. At a briefing for state lawmakers, the officials said they face challenges with the amount of work to be done and the lack of answers on key matters.
Researchers at Johns Hopkins have discovered that cancers arising from epigenetic changes - in this case the inappropriate activation of a normally silent gene - develop by becoming addicted to certain growth factors.
The World Health Organization Framework Convention on Tobacco Control (WHO FCTC) entered into force today. This represents an historical moment in public health, as the Treaty gives countries more tools to control tobacco use and save lives.
Dental implants are now a common way to replace a tooth. But a dentist must first determine that an implant restoration can be successful for a particular patient. As an indicator, dentists use the crown-to-root ratio—how much of the tooth extends above the jawbone and how much is in the bone. However, the ideal crown-to-implant ratio for the replacement tooth has yet to be determined.
› Verified 5 days ago
Eddy Karnabi, MD PHD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Northeast Dr, Bangor, ME 04401 Phone: 207-275-3800 | |
Dr. Theodore William James, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 417 State St Ste 121, Bangor, ME 04401 Phone: 207-973-4266 | |
Fnu Kaleemullah, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 489 State St, Bangor, ME 04401 Phone: 207-973-7314 | |
Sverrir I Gunnarsson, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Northeast Dr, Bangor, ME 04401 Phone: 207-275-3800 | |
Liga Yusvirazi, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 360 Broadway, Bangor, ME 04401 Phone: 207-907-3283 | |
Ilsa Annetta Shulman, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 900 Broadway, Bangor, ME 04401 Phone: 207-907-3300 Fax: 207-907-1923 | |
Dr. Michael Paul Sighinolfi, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 360 Broadway Ste 100, Bangor, ME 04401 Phone: 207-907-3550 Fax: 207-907-3562 |